Even in Kindergarten, White Kids More Likely to Join Extracurricular Activities
TUESDAY, Nov. 15, 2022 (HealthDay News) — Extracurricular activities may have many benefits for young children, but researchers have discovered racial gaps in who takes part.Among a group of 401 kindergarten students in Ohio, white children were 2.6 …
Learn MoreLow Vitamin D Could Raise Diabetes Risk for Black Americans
FRIDAY, Nov. 11, 2022 (HealthDay News) – Too little of the “sunshine vitamin” — vitamin D — in Black Americans could raise their odds of developing diabetes, new research suggests. Two new studies found an association between levels of vitamin D in …
Learn MoreUrban-Dwelling Indigenous Young People Face Higher Burden of Skin Conditions
THURSDAY, Nov. 10, 2022 (HealthDay News) — A significant burden of atopic dermatitis and bacterial skin infections exists in urban-living Indigenous children and young people in high-income countries, according to a review published online Nov. 9 in …
Learn MoreHealth Care Access May Affect Receipt of Therapy in Ovarian Cancer
THURSDAY, Nov. 10, 2022 (HealthDay News) — Health care access (HCA) dimensions are associated with receipt of guideline-concordant therapy, but they do not fully explain racial disparities among patients with ovarian cancer, according to a study publ…
Learn MoreOverall Cancer Mortality 18 Percent Higher in AI/AN Versus Whites
TUESDAY, Nov. 8, 2022 (HealthDay News) — Overall cancer rates are 2 percent higher and cancer mortality is 18 percent higher for American Indian and Alaska Native (AIAN) individuals compared with White individuals, according to a report published onl…
Learn MoreTelmisartan Linked to Reduced Risk for Alzheimer Disease in Black Patients
MONDAY, Nov. 7, 2022 (HealthDay News) — In African American patients, telmisartan is associated with a reduced risk for Alzheimer disease (AD), according to a study published online Nov. 4 in Alzheimer’s & Dementia.Pengyue Zhang, Ph.D., from Indiana …
Learn MoreUn antihipertensivo común podría prevenir el Alzheimer en los pacientes negros
VIERNES, 4 de noviembre de 2022 (HealthDay News) — Un nuevo estudio ha mostrado que el antihipertensivo telmisartán podría ofrecer esperanza como tratamiento para el Alzheimer en los pacientes negros. No mostró el mismo beneficio para las personas bl…
Learn MoreCKD Incidence Differs by Race in People With Diabetes
MONDAY, Nov. 7, 2022 (HealthDay News) — A high incidence of chronic kidney disease (CKD) persists among U.S. patients with diabetes, with differences seen across racial and ethnic groups, according to a letter to the editor published in the Oct. 13 i…
Learn MoreCommon Blood Pressure Drug Might Prevent Alzheimer’s in Black Patients
FRIDAY, Nov. 4, 2022 (HealthDay News) — A new study has shown the blood pressure drug telmisartan may offer new hope as an Alzheimer’s treatment in Black patients. It did not show the same benefit in white people.Learning how people from different et…
Learn MorePhysicians Say Faulty Oxygen Devices Put Lives in Peril
THURSDAY, Nov. 3, 2022 (HealthDay News) — Faulty readings by pulse oximeters may have resulted in more COVID-19 deaths among minorities, doctors warned in testimony before a U.S. Food and Drug Administration advisory panel this week.The devices appea…
Learn More